| Not Yet Recruiting | Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radio Head & Neck Cancer | N/A | 2026-07-01 |
| Not Yet Recruiting | BR101 in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma (MM) | Phase 1 | 2026-04-30 |
| Not Yet Recruiting | The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy Esophageal Cancer | N/A | 2026-04-01 |
| Not Yet Recruiting | Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy Pancreaticoduodenectomy, Nasogastric Tube Decompression, Minimally Invasive Surgical Procedures | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer Prostate Cancer | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoad Local Advanced Esophageal Cancer | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma | N/A | 2026-04-01 |
| Enrolling By Invitation | Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Urothelial Carcinoma (UC), HER2, Diagnostic | — | 2026-03-02 |
| Recruiting | The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Follicular, Lymphoma, Mantle-Cell | N/A | 2026-03-01 |
| Not Yet Recruiting | Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous High-grade Serous Ovarian Cancer (HGSOC), Fallopian Tube Cancers, Primary Peritoneal Cancer | Phase 2 | 2026-03-01 |
| Recruiting | Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring Bladder Cancer | — | 2026-03-01 |
| Not Yet Recruiting | Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC NSCLC Stage IV, KRAS G12C | Phase 1 / Phase 2 | 2026-03-01 |
| Recruiting | A Retrospective Real-World Study Based on RATIONALE-307 NSCLC (Advanced Non-small Cell Lung Cancer) | — | 2026-02-28 |
| Not Yet Recruiting | Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients SCLC, Extensive Stage, Neuroendocrine Tumors | Phase 1 | 2026-02-20 |
| Not Yet Recruiting | Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Breast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast Cancer | Phase 2 | 2026-02-15 |
| Not Yet Recruiting | Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02) Soft Tissue Sarcoma (STS), Retroperitoneal Sarcoma, Immunotherapy | N/A | 2026-02-12 |
| Not Yet Recruiting | Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Vers Triple Negative Breast Cancer Metastatic | Phase 2 | 2026-02-10 |
| Not Yet Recruiting | An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Liver Metastases | Phase 1 | 2026-02-10 |
| Recruiting | Response-Based Local Therapy for Regionally Advanced Breast Cancer Breast Cancer | Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy Muscle-invasive Bladder Cancer | — | 2026-02-01 |
| Recruiting | Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer Colo-rectal Cancer (dMMR/MSI-H CRC) | — | 2026-02-01 |
| Not Yet Recruiting | A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer Breast Cancer | Phase 3 | 2026-02-01 |
| Not Yet Recruiting | A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumo Advanced Malignant Tumors | EARLY_Phase 1 | 2026-01-31 |
| Not Yet Recruiting | Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-base Renal Cell Carcinoma (Kidney Cancer) | — | 2026-01-25 |
| Not Yet Recruiting | Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors Advanced Solid Tumor | N/A | 2026-01-20 |
| Not Yet Recruiting | BaiXiaoAi AI Companion for Cancer Patient Follow-up Symptoms and Signs, Artificial Intelligence, Artificial Intelligence Mobile Application | — | 2026-01-14 |
| Recruiting | Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Ad Advanced Solid Tumors | EARLY_Phase 1 | 2026-01-10 |
| Recruiting | Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites Ovarian Neoplasms Malignant, Ascites | Phase 1 / Phase 2 | 2026-01-05 |
| Not Yet Recruiting | Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 / Phase 2 | 2026-01-01 |
| Not Yet Recruiting | Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Carcinoma, Non-Small-Cell Lung, Neoadjuvant Immunotherapy, Surgery | — | 2026-01-01 |
| Not Yet Recruiting | Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND) Colon Cancer, Rectal Cancer | — | 2026-01-01 |
| Active Not Recruiting | Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junc Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma | — | 2026-01-01 |
| Active Not Recruiting | Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymph Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 | 2026-01-01 |
| Active Not Recruiting | Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma B-Cell Non-Hodgkin Lymphoma | — | 2026-01-01 |
| Not Yet Recruiting | An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing SCLC, Extensive Stage | Phase 1 / Phase 2 | 2025-12-31 |
| Not Yet Recruiting | Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Metastatic Colorectal Cancer (CRC), Colorectal Cancer | Phase 2 | 2025-12-31 |
| Recruiting | An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metasta Prostate Cancer Castration-resistant Prostate Cancer | EARLY_Phase 1 | 2025-12-18 |
| Not Yet Recruiting | This Study is an Open-lable, Phase I Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Relapsed/Refractory Small Cell Lung Cancer | Phase 1 | 2025-11-21 |
| Recruiting | A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening Advanced Malignant Tumours | EARLY_Phase 1 | 2025-11-21 |
| Not Yet Recruiting | A Multicenter Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escala Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy | Phase 3 | 2025-11-16 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for H Resectable Hepatocellular Carcinoma With High Risk of Recurrence | Phase 2 | 2025-11-12 |
| Recruiting | Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC LOCALLY ADVANCED CERVICAL CANCERS | Phase 2 | 2025-11-11 |
| Recruiting | Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC SCLC, SCLC, Extensive Stage | Phase 2 | 2025-10-31 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC Lung Cancer (NSCLC) | Phase 2 | 2025-10-28 |
| Not Yet Recruiting | QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer Recurrent Cervical Cancer, Metastatic Cervical Cancer | — | 2025-10-15 |
| Active Not Recruiting | Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZL Marginal Zone Lymphoma(MZL) | Phase 2 | 2025-10-01 |
| Not Yet Recruiting | Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma Neuroendocrine Carcinomas (NEC) | Phase 2 | 2025-10-01 |
| Not Yet Recruiting | Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer Breast Cancer | N/A | 2025-10-01 |
| Recruiting | Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases Colorectal Liver Metastases | Phase 2 | 2025-09-18 |
| Recruiting | A Phase I Study of CREPT-618 in Locally Advanced HCC Hepatocellular Carcinoma (HCC) | Phase 1 | 2025-09-15 |
| Recruiting | Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer Prostate Cancer Castration-resistant Prostate Cancer | EARLY_Phase 1 | 2025-09-01 |
| Not Yet Recruiting | Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Cervical Carcinoma | Phase 2 | 2025-09-01 |
| Not Yet Recruiting | SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer Metastatic Breast Cancer With HER2 Positive | Phase 2 | 2025-08-30 |
| Recruiting | Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. Whole-Brain Radiotherapy | Phase 3 | 2025-08-29 |
| Recruiting | Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) Thrombocytopenia, Cancer | Phase 1 | 2025-08-28 |
| Recruiting | CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC Medullary Thyroid Carcinoma | Phase 3 | 2025-08-25 |
| Not Yet Recruiting | Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Ad Breast Cancer | — | 2025-08-25 |
| Not Yet Recruiting | Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction Breast Cancer, Breast Reconstruction, Radiation Oncology | Phase 3 | 2025-08-10 |
| Not Yet Recruiting | Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast HER2-negative Breast Cancer, Recurrence, Metastasis | — | 2025-08-01 |
| Not Yet Recruiting | A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Cancer (MTC) | — | 2025-08-01 |
| Not Yet Recruiting | the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer Rectal Cancer, Adaptive Radiotherapy | N/A | 2025-08-01 |
| Not Yet Recruiting | A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary Biliary Tract Cancer (BTC) | Phase 2 | 2025-08-01 |
| Active Not Recruiting | Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/ Langerhans Cell Histiocytosis (LCH) | Phase 2 | 2025-08-01 |
| Recruiting | Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC Non-small Cell Lung Cancer (NSCLC), II-IIIB | Phase 2 | 2025-07-30 |
| Recruiting | Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC Hepatocellular Carcinoma (HCC), Radiotherapy, Adjuvant, Immune Checkpoint Inhibitor | Phase 3 | 2025-07-10 |
| Not Yet Recruiting | Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients Solid Tumors, Hematological Tumor, Children | Phase 2 | 2025-07-01 |
| Not Yet Recruiting | Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer HER2-positive Breast Cancer, Metastatic Breast Cancer | Phase 2 | 2025-06-30 |
| Recruiting | Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib Ovarian Cancer | Phase 2 | 2025-06-25 |
| Recruiting | Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Im Non-Small Cell Lung Cancer | Phase 2 | 2025-06-11 |
| Recruiting | Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Gastric Adenocarcinoma | EARLY_Phase 1 | 2025-06-01 |
| Recruiting | Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Locally Advanced Rectal Cancer (LARC) | Phase 2 | 2025-06-01 |
| Recruiting | A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Chola Intrahepatic Cholangiocarcinoma (Icc), Adjuvant Chemoradiotherapy, Narrow Margin | Phase 2 | 2025-05-16 |
| Recruiting | Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer Colorectal Cancer (CRC), Neoadjuvant Therapy, Proteomics | — | 2025-05-01 |
| Recruiting | Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer Lung Cancer, Non-Small Cell, Immunotherapy | — | 2025-04-20 |
| Recruiting | Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease Rosai-Dorfman Disease | Phase 2 | 2025-04-12 |
| Recruiting | Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH Langerhans Cell Histiocytosis | Phase 2 | 2025-04-12 |
| Not Yet Recruiting | Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2025-04-09 |
| Not Yet Recruiting | Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Solid Tumors, Children, Adolescent | Phase 2 | 2025-04-07 |
| Not Yet Recruiting | Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Th Triple-Negative Breast Cancer (TNBC), Neoadjuvant Therapy | Phase 2 / Phase 3 | 2025-04-02 |
| Not Yet Recruiting | Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy Esophageal Cancer | — | 2025-04-01 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neo HER2-Negative Locally Advanced Breast Cancer | Phase 2 | 2025-03-31 |
| Enrolling By Invitation | A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-rad Rectal Cancer, Adenocarcinoma | — | 2025-03-15 |
| Not Yet Recruiting | Jianzhong Qushi in Chronic RRI Chronic Radiation Proctitis | Phase 3 | 2025-03-15 |
| Not Yet Recruiting | A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tum Advanced Breast Cancer Brain Metastasis | — | 2025-03-01 |
| Not Yet Recruiting | Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Ty Colorectal Cancer | — | 2025-03-01 |
| Not Yet Recruiting | Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Brain Metastasis from Advanced HER2-negative Breast Cancer | Phase 2 | 2025-03-01 |
| Recruiting | Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma | Phase 2 | 2025-02-28 |
| Not Yet Recruiting | Familial Breast Cancer in China Breast Carcinoma, Genetic Variation | — | 2025-02-28 |
| Recruiting | Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Advanced Lung Cancer, Lung Metastasis | EARLY_Phase 1 | 2025-02-24 |
| Not Yet Recruiting | QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC Pancreatic Adenocarcinoma | Phase 2 | 2025-02-15 |
| Completed | Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy Chylous Ascites, Abdominal Neoplasm, Pelvic Neoplasms | Phase 2 | 2025-02-15 |
| Not Yet Recruiting | Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002 NF2 Deficiency | N/A | 2025-02-15 |
| Not Yet Recruiting | PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer Breast Cancer | Phase 2 | 2025-02-01 |
| Not Yet Recruiting | A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Rel Solid Tumors, Children, Adolescents | Phase 2 | 2025-02-01 |
| Not Yet Recruiting | Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibod Breast Cancer Invasive | Phase 2 | 2025-02-01 |
| Recruiting | Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic C Pancreatic Adenocarcinoma | Phase 2 | 2025-01-25 |
| Enrolling By Invitation | A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2- Breast | — | 2025-01-19 |
| Recruiting | Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma | Phase 2 | 2025-01-17 |
| Recruiting | A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Small Cell Lung Cancer | — | 2025-01-01 |
| Recruiting | Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small C Non Small Cell Lung Cancer | — | 2025-01-01 |
| Not Yet Recruiting | Quantitative Neurofeedback Techniques for Treating Perioperative Cognitive Disorders in Elderly Patients Emergence Delirium, Perioperative Neurocognitive Disorder | N/A | 2025-01-01 |
| Recruiting | Zanubrutinib Combined With G-CVP in Previously Untreated FL Follicular Lymphoma ( FL) | Phase 2 | 2025-01-01 |
| Recruiting | Multi-Reader Multi-Case Trial Evaluating Computer-Aided Tool for Prognostic Prediction of Colorectal Liver Met Colorectal Liver Metastasis (CRLM) | — | 2025-01-01 |
| Enrolling By Invitation | A Study Comparing the Differences Between Young and Non-young Breast Cancer Breast Cancer | — | 2025-01-01 |
| Recruiting | Adaptive Radiotherapy for Genitourinary Cancers Prostate Cancer (Post Prostatectomy), Bladder Cancer | N/A | 2024-12-01 |
| Recruiting | A Study of ES014 in Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 2 | 2024-11-25 |
| Completed | The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients Colon Cancer | — | 2024-10-24 |
| Recruiting | Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer Breast Carcinoma | Phase 3 | 2024-10-10 |
| Recruiting | A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensi Advanced Breast Cancer | — | 2024-09-24 |
| Recruiting | Phase II Clinical Trial of PD-L1 in Combination with Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metro Advanced Triple-negative Breast Cancer | Phase 2 | 2024-09-10 |
| Recruiting | First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesotheli Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced | Phase 2 | 2024-09-01 |
| Not Yet Recruiting | A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma, RCC, Kidney Cancer | N/A | 2024-09-01 |
| Not Yet Recruiting | Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients Kidney Cancer, RCC, Renal Cell Carcinoma | Phase 1 / Phase 2 | 2024-08-31 |
| Recruiting | Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carci Nasopharyngeal Carcinoma by AJCC V8 Stage | Phase 2 | 2024-08-30 |
| Enrolling By Invitation | A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma (ESCC) | N/A | 2024-08-22 |
| Recruiting | Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors Nerve Sheath Tumor | Phase 2 | 2024-08-15 |
| Not Yet Recruiting | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases Breast Cancer, Bone Metastases | — | 2024-08-06 |
| Not Yet Recruiting | GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma Locally Advanced Nasopharyngeal Carcinoma | Phase 2 | 2024-07-20 |
| Recruiting | NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors Safety Issues | N/A | 2024-07-17 |
| Recruiting | MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer Esophageal Cancer | Phase 2 | 2024-07-16 |
| Not Yet Recruiting | An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy Small Cell Lung Carcinoma | Phase 2 | 2024-07-01 |
| Not Yet Recruiting | Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases Adenocarcinoma of Lung Metastatic to Brain | Phase 2 | 2024-07-01 |
| Recruiting | Trilaciclib Prevents Myelosuppression With Chemoradiotherapy Myelosuppression | Phase 2 | 2024-06-26 |
| Not Yet Recruiting | Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma Pleural Mesothelioma | Phase 2 | 2024-06-20 |
| Recruiting | Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy Advanced Solid Tumor | Phase 2 | 2024-06-04 |
| Not Yet Recruiting | Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. Non-small Cell Lung Cancer | Phase 2 | 2024-06-01 |
| Recruiting | Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy Chemoradiotherapy | Phase 2 | 2024-05-29 |
| Recruiting | Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials Cancer | Phase 1 / Phase 2 | 2024-05-24 |
| Active Not Recruiting | Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC Biliary Tract Cancer | Phase 2 | 2024-05-24 |
| Recruiting | SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer Breast Cancer | Phase 2 | 2024-05-16 |
| Not Yet Recruiting | Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer Liver Cancer | Phase 2 | 2024-05-15 |
| Recruiting | Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer Endometrial Carcinoma, TP53 Mutation, Recurrent or Metastatic | Phase 2 | 2024-05-10 |
| Enrolling By Invitation | Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients Breast Neoplasms, Lipid Profile | — | 2024-05-06 |
| Enrolling By Invitation | Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation Breast Carcinoma, BRCA Mutation, Adjuvant Drug Therapy | — | 2024-05-06 |
| Recruiting | Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thr Hepatocellular Carcinoma, Radiotherapy, Pembrolizumab | Phase 2 | 2024-05-01 |
| Recruiting | Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal C Colorectal Cancer | Phase 2 | 2024-05-01 |
| Recruiting | Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer Esophageal Cancer, Immunotherapy, Induction Therapy | Phase 2 | 2024-05-01 |
| Active Not Recruiting | Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer Cervical Cancer | Phase 2 | 2024-05-01 |
| Recruiting | The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditiona HER2 Positive Breast Cancer, Pyrotinib Treatment | Phase 2 / Phase 3 | 2024-04-30 |
| Recruiting | NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC Nanoliposomal Irinotecan, Cadonilimab, Oxaliplatin | Phase 2 | 2024-04-17 |
| Recruiting | Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Aden Gastric Cancer | — | 2024-04-15 |
| Recruiting | Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors Neoplasms | EARLY_Phase 1 | 2024-04-12 |
| Active Not Recruiting | Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma PTCL | Phase 2 | 2024-04-03 |
| Completed | Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors Solid Tumor, Meningeal Metastasis | N/A | 2024-04-01 |
| Recruiting | Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer Esophagus Cancer | Phase 2 | 2024-04-01 |
| Recruiting | Goal-directed Enteral Nutritional Perioperative Management Esophagus Cancer | N/A | 2024-03-30 |
| Active Not Recruiting | Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Locally Advanced Esophageal Squamous Cell Carcinoma, Sintilimab, Radiotherapy | Phase 2 | 2024-03-14 |
| Unknown | NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study Borderline Resectable Pancreatic Cancer | Phase 2 | 2024-03-10 |
| Recruiting | Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy NSCLC | — | 2024-03-01 |
| Recruiting | Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery Lung Cancer | — | 2024-03-01 |
| Not Yet Recruiting | Clinical Trial for Advanced or Metastatic Pancreatic Cancer Pancreas Cancer | Phase 2 | 2024-03-01 |
| Unknown | The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer Locally Advanced Non-small Cell Lung Cancer | — | 2024-03-01 |
| Recruiting | Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC Gastric Cancer, Diffuse Type Carcinoma | Phase 2 | 2024-03-01 |
| Enrolling By Invitation | Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer GASTROINTESTINAL NEOPLASMS | — | 2024-03-01 |
| Recruiting | PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer Esophageal Neoplasms | Phase 3 | 2024-02-04 |
| Not Yet Recruiting | RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, ERBB2 Gene Duplication | Phase 2 | 2024-02-01 |
| Unknown | Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC Pancreatic Cancer, Radiotherapy, Envafolimab | Phase 2 | 2024-01-31 |
| Recruiting | Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM Malignant Peritoneal Mesothelioma, Advanced | Phase 2 | 2024-01-31 |
| Not Yet Recruiting | Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Ca Breast Cancer | Phase 4 | 2024-01-30 |
| Recruiting | Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. Hepatocellular Carcinoma, Narrow Margin, Radiotherapy | Phase 2 | 2024-01-26 |
| Completed | Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thro Hepatocellular Carcinoma, Radiotherapy, Tislelizumab | Phase 2 | 2024-01-25 |
| Recruiting | Clinical Trial of BT02 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2024-01-24 |
| Recruiting | Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) Stage IVB Lung Cancer, Non-Squamous | Phase 2 | 2024-01-23 |
| Unknown | Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules Adenocarcinoma of Lung | — | 2024-01-22 |
| Not Yet Recruiting | Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Brea Breast Cancer, Triple Negative Breast Cancer | Phase 2 | 2024-01-19 |
| Recruiting | Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer Breast Cancer, Familial Male, Radiotherapy; Complications, Chemotherapeutic Toxicity | N/A | 2024-01-12 |
| Active Not Recruiting | Toripalimab for High-risk Locally Advanced Cervical Cancer Cervical Cancers | Phase 2 | 2024-01-09 |
| Recruiting | Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy o Breast Cancer | — | 2024-01-01 |
| Recruiting | Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC Head and Neck Cancer | Phase 2 | 2024-01-01 |
| Enrolling By Invitation | Hypofractionated Radiotherapy for HNSCC in Elderly Patients Head and Neck Cancer Squamous Cell Carcinoma, ELDERLY PEOPLE, Hypofractionation | N/A | 2024-01-01 |
| Recruiting | Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuv Ampullary Adenoma, Chemotherapy Effect | — | 2024-01-01 |
| Not Yet Recruiting | Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-S Non-Small-Cell Lung Cancer | Phase 2 | 2024-01-01 |
| Recruiting | NV-001 in the Treatment of Advanced Solid Tumors Malignant Neoplasm | Phase 1 | 2023-12-01 |
| Recruiting | ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2023-12-01 |
| Recruiting | Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H) Rectal Cancer | N/A | 2023-12-01 |
| Recruiting | Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-12-01 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Pati Thrombosis, Venous, Cancer, Catheter Complications | Phase 3 | 2023-11-30 |
| Unknown | Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Breast Cancer | N/A | 2023-11-28 |
| Active Not Recruiting | Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection Thymus Neoplasms | N/A | 2023-11-11 |
| Recruiting | Personalized KSX01-TCRT in Patients With Advanced Solid Tumors Refractory Solid Tumors, Relapsed Solid Tumors | EARLY_Phase 1 | 2023-11-07 |
| Recruiting | Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanc Locally Advanced Colorectal Carcinoma | Phase 2 | 2023-11-01 |
| Recruiting | Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy Esophageal Neoplasm Metastatic, Esophageal Cancer Stage IVb | Phase 2 | 2023-10-16 |
| Unknown | A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumo Malignant Solid Tumors | Phase 1 / Phase 2 | 2023-10-01 |
| Unknown | A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumo Advanced Solid Tumors | Phase 1 / Phase 2 | 2023-10-01 |
| Recruiting | 68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC Medullary Thyroid Cancer, Prositron Emission Tomography, Fibroblast Activation Protein Inhibitor | N/A | 2023-10-01 |
| Recruiting | An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Trea Neuroendocrine Tumors | Phase 1 / Phase 2 | 2023-09-15 |
| Unknown | A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer Muscle Invasive Bladder Carcinoma | Phase 2 | 2023-09-10 |
| Recruiting | Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer Colorectal Cancer, Lymph Node Metastasis | — | 2023-09-01 |
| Recruiting | SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC Small-cell Lung Cancer, Brain Metastases, SRS | Phase 3 | 2023-09-01 |
| Not Yet Recruiting | Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer Colorectal Neoplasms, Fluorescence, Lymph Node Excision | N/A | 2023-09-01 |
| Not Yet Recruiting | Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer Breast Cancer, Neoadjuvant Therapy | Phase 2 | 2023-09-01 |
| Completed | Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection Colorectal Cancer | — | 2023-09-01 |
| Not Yet Recruiting | The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC Lung Neoplasms | Phase 2 | 2023-08-01 |
| Not Yet Recruiting | The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negativ Gastroesophageal Adenocarcinoma | Phase 1 / Phase 2 | 2023-08-01 |
| Recruiting | Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer HR+/HER2- Advanced Breast Cancer, Targeted Therapy | Phase 2 | 2023-07-20 |
| Recruiting | XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC Tislelizumab, Bevacizumab, Oxaliplatin | Phase 2 | 2023-07-07 |
| Recruiting | LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer Lung Cancer | Phase 1 / Phase 2 | 2023-05-11 |
| Unknown | 68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor | N/A | 2023-05-05 |
| Unknown | Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mes Fluorescence, Indocyanine Green, Rectal Cancer Surgery | N/A | 2023-05-01 |
| Completed | Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03) Soft Tissue Sarcoma | Phase 2 | 2023-05-01 |
| Not Yet Recruiting | MSLN-targeted CAR-T Cells in Solid Tumors. Mesothelin-positive Advanced Malignant Solid Tumors | Phase 1 | 2023-04-01 |
| Unknown | Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer dMMR Colorectal Cancer | Phase 2 | 2023-03-29 |
| Unknown | XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer Rectal Cancer, MSS | Phase 2 | 2023-03-29 |
| Active Not Recruiting | Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Vinorelbine | Phase 2 | 2023-03-20 |
| Recruiting | Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinom Esophageal Cancer, Nimotuzumab, Chemoradiotherapy | Phase 2 | 2023-03-01 |
| Recruiting | Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy Gastric Cancer | N/A | 2023-03-01 |
| Unknown | Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-03-01 |
| Recruiting | Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients Esophageal Cancer, Nimotuzumab, Chemoradiotherapy | Phase 2 | 2023-03-01 |
| Unknown | RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody Breast Cancer Stage IV | — | 2023-02-01 |
| Enrolling By Invitation | Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of Hepatocellular Carcinoma | — | 2023-02-01 |
| Unknown | Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer Locally Recurrent Colorectal Cancer | — | 2023-01-30 |
| Active Not Recruiting | Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC Local Advanced Non-small Cell Lung Cancer | Phase 2 | 2023-01-20 |
| Unknown | Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins Malignancy | Phase 2 / Phase 3 | 2023-01-08 |
| Recruiting | MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer Biliary Tract Cancer | N/A | 2023-01-01 |
| Unknown | To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2 COVID-19 Infection, COVID-19 Vaccine | — | 2023-01-01 |
| Recruiting | Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy Head and Neck Cancer | Phase 2 | 2023-01-01 |
| Completed | Multivisceral Radical Resection for Surgical T4b Colorectal Cancer: Propensity Score-matched Study Comparing t Colorectal Cancer | — | 2023-01-01 |
| Recruiting | Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression SSTR Positive Tumors | Phase 2 / Phase 3 | 2022-12-20 |
| Active Not Recruiting | Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC Esophageal Squamous Cell Carcinoma, Oligometastatic Disease | N/A | 2022-11-01 |
| Unknown | Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer Breast Cancer, Chemotherapy Effect | Phase 1 / Phase 2 | 2022-11-01 |
| Recruiting | Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patien Breast Cancer, Radiotherapy Side Effect | Phase 2 | 2022-10-25 |
| Recruiting | Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor Malignancy | Phase 2 | 2022-10-13 |
| Recruiting | Perioperative Analgesia Modes in Minimally Invasive Esophagectomy Esophageal Cancer, Perioperative Analgesia, NSAIDs | Phase 2 / Phase 3 | 2022-10-10 |
| Recruiting | Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2022-10-01 |
| Completed | A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemothera Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin | N/A | 2022-10-01 |
| Completed | Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophage Esophageal Cancer | N/A | 2022-09-30 |
| Recruiting | Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients Limited Stage Small Cell Lung Cancer | Phase 2 | 2022-09-23 |
| Completed | Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases Brain Metastases, Adult | N/A | 2022-09-01 |
| Completed | Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery Esophageal Cancer | N/A | 2022-09-01 |
| Recruiting | Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junctio Gastroesophageal Junction Adenocarcinoma (Siewert II-III) | Phase 2 | 2022-08-25 |
| Active Not Recruiting | Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients Metastatic Colorectal Cancer | Phase 2 | 2022-08-01 |
| Recruiting | Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma Thyroid Cancer, Surgery, Recurrence | Phase 2 | 2022-08-01 |
| Unknown | Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC Esophageal Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2022-08-01 |
| Recruiting | A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dis Thyroid Cancer, Recurrence | Phase 3 | 2022-07-01 |
| Unknown | Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients Radiation Dermatitis, Head and Neck Cancer | — | 2022-07-01 |
| Recruiting | Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma Siewert Type II Adenocarcinoma of Esophagogastric Junction | N/A | 2022-07-01 |
| Unknown | Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastri Gastric Cancer | Phase 2 | 2022-06-28 |
| Recruiting | A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Breast Neoplasms | N/A | 2022-06-21 |
| Not Yet Recruiting | The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast C Advanced Breast Cancer | Phase 2 | 2022-06-01 |
| Recruiting | ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy Patients With Advanced Solid Tumors | Phase 1 | 2022-05-25 |
| Unknown | Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma Metastatic Nasopharyngeal Cancer | Phase 2 | 2022-05-05 |
| Completed | Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER Gastric Cancer | — | 2022-05-01 |
| Unknown | Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence Colorectal Adenoma, Colorectal Cancer | — | 2022-05-01 |
| Active Not Recruiting | Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma (ESCC), Cervical Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma | — | 2022-04-28 |
| Recruiting | Super-Hypofractionated Partial Breast Irradiation Breast Cancer, Radiotherapy Side Effect | N/A | 2022-04-22 |
| Unknown | Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105 Hand and Foot Skin Reaction, Colorectal Cancer Stage IV | Phase 2 | 2022-04-18 |
| Recruiting | Surgery or Chemoradiotherapy for Cervical Esophageal Cancer Cervical Esophageal Cancer | N/A | 2022-04-10 |
| Unknown | A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of Metastatic Breast Cancer | Phase 2 | 2022-04-01 |
| Recruiting | Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer Early-stage Breast Cancer | N/A | 2022-03-24 |
| Unknown | A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treat Colorectal Cancer | Phase 2 | 2022-02-01 |
| Unknown | A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoad Breast Cancer | Phase 2 | 2022-02-01 |
| Unknown | Carbon Nanoparticles and Indocyanine Green for Sentinel Lymph Node Biopsy in Early Stage Cervical Cancer Cervical Cancer Stage IB1 | N/A | 2022-02-01 |
| Unknown | Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer Breast Cancer | Phase 2 | 2022-01-01 |
| Recruiting | Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC Non-Small Cell Lung Cancer | — | 2022-01-01 |
| Recruiting | Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01) Soft Tissue Sarcoma, Retroperitoneal Sarcoma, Radiotherapy Side Effect | N/A | 2022-01-01 |
| Unknown | Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer Locally Advanced Breast Cancer, Chemotherapy Effect | Phase 2 | 2021-11-01 |
| Completed | Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02） Sarcoma,Soft Tissue, Extremity, Trunk | Phase 2 | 2021-09-01 |
| Unknown | Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2021-09-01 |
| Active Not Recruiting | Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases Whole Brain Radiotherapy | Phase 2 | 2021-08-20 |
| Unknown | Multi-center Study of Deep Learning AI in Breast Mass Breast Neoplasms | — | 2021-08-12 |
| Unknown | Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatm Lung Cancer Stage II | N/A | 2021-07-31 |
| Unknown | SBRT With DIBH for HCC After TACE and Lipiodol Marking Hepatocellular Carcinoma | N/A | 2021-07-21 |
| Completed | A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy Cancer | — | 2021-06-01 |
| Active Not Recruiting | Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix Uterine Cervical Neoplasms | Phase 2 | 2021-05-12 |
| Unknown | A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin Hepatocellular Carcinoma Resectable | Phase 2 | 2021-05-06 |
| Completed | Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC Hepatocellular Carcinoma, Radiotherapy, Lenvatinib | Phase 2 | 2021-04-12 |
| Unknown | Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT Cancer | — | 2021-03-23 |
| Terminated | Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT Radiotherapy, Toripalimab, Sorafenib | Phase 3 | 2021-03-02 |
| Recruiting | MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02) Prostate Cancer, Radiotherapy Side Effect, Magnetic Resonance-linac | N/A | 2021-02-01 |
| Unknown | Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Pati Biosimilar | — | 2021-01-01 |
| Completed | Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC Lung Cancer (NSCLC) | — | 2021-01-01 |
| Unknown | MRI-guided Lateral Lymph Node Dissection in Rectal Cancer Rectal Cancer | — | 2021-01-01 |
| Completed | To Evaluate the Efficacy and Safety of Anlotinib Combined With Furmonertinib Mesylate in Lung Cancer Lung Cancer | Phase 2 | 2021-01-01 |
| Unknown | Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC Tislelizumab, Chemotherapy, First-line | — | 2020-11-01 |
| Unknown | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Non Small Cell Lung Cancer | Phase 3 | 2020-10-01 |
| Completed | Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer Esophagus Cancer, Chemoradiotherapy, Oligometastatic Disease | Phase 2 | 2020-10-01 |
| Unknown | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Non Small Cell Lung Cancer | Phase 3 | 2020-10-01 |
| Unknown | Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer NSCLC | Phase 2 | 2020-09-15 |
| Unknown | Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 N HER2-negative Breast Cancer | Phase 2 | 2020-09-01 |
| Unknown | A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer Rectal Cancer | Phase 2 | 2020-08-15 |
| Recruiting | PLATFORM Study of Precision Medicine for Rare Tumors Rare Tumor | Phase 2 | 2020-08-15 |
| Recruiting | Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor Neuroendocrine Tumors | Phase 2 | 2020-07-01 |
| Active Not Recruiting | Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients Breast Cancer | Phase 3 | 2020-05-08 |
| Recruiting | Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma （SPARE-01） Sarcoma,Soft Tissue, Extremity, Trunk | Phase 2 | 2020-05-01 |
| Unknown | Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelb Metastatic Breast Cancer | Phase 2 | 2020-04-01 |
| Unknown | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Ca Esophageal Neoplasms | N/A | 2020-04-01 |
| Unknown | Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Can Extensive Stage Small Cell Lung Cancer | Phase 2 | 2020-01-31 |
| Unknown | Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases Brain Metastases | — | 2020-01-03 |
| Active Not Recruiting | Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients Lung Cancer (NSCLC) | — | 2020-01-01 |
| Completed | A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer Esophageal Cancer, Chemoradiotherapy, Nimotuzumab | Phase 2 | 2019-11-14 |
| Recruiting | Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers Lung Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma | — | 2019-11-04 |
| Unknown | Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma Upper Tract Urinary Carcinoma, Muscle-invasive Bladder Cancer | Phase 2 | 2019-10-01 |
| Recruiting | Chemoradiotherapy in Unresectable Esophageal Cancer Esophageal Cancer, Chemoradiotherapy, Albumin-bound Paxlitaxel | Phase 1 / Phase 2 | 2019-10-01 |
| Completed | Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC Stage II-III Non-small Cell Lung Cancer, Concurrent Chemotherapy, Conditions Influencing Health Status | — | 2019-09-02 |
| Unknown | Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer Breast Cancer | — | 2019-08-23 |
| Unknown | Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resec Hepatocellular Carcinoma | Phase 2 | 2019-02-15 |
| Unknown | The Influence of Treatment Position (Prone vs. Supine) on Whole Breast Target Breast Cancer | N/A | 2019-01-01 |
| Recruiting | Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surger Colorectal Cancer | N/A | 2019-01-01 |
| Unknown | Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Tripl Triple-negative Breast Cancer | Phase 2 | 2018-12-18 |
| Recruiting | MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer Rectal Neoplasms | Phase 2 | 2018-10-23 |
| Unknown | A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Pre CYP2D6 Polymorphism | Phase 3 | 2018-08-09 |
| Unknown | Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells) Thyroid Nodule, Diagnoses Disease | N/A | 2018-07-25 |
| Completed | Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Hepatocellular Carcinoma, Radiotherapy, Sorafenib | Phase 2 | 2018-05-08 |
| Unknown | Daytime Variation of Complication in Gastric and Pancreatic Surgery Gastrointestinal Dysfunction, Hemorrhage, Infection | — | 2018-01-01 |
| Completed | A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer Breast Neoplasms, Hypothyroidism, Radiation Toxicity | — | 2017-11-15 |
| Unknown | Perioperative Electroacupuncture After Operation Acupuncture, Gastrointestinal Function | N/A | 2017-08-01 |
| Unknown | Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy Acupuncture, Gastrointestinal Function | N/A | 2017-07-29 |
| Completed | Randomized Trial of Accelerated Partial Breast Irradiation Breast Neoplasms, Neoplasm Recurrence, Local | N/A | 2017-07-19 |
| Active Not Recruiting | Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer Breast Neoplasms, Neoplasm Recurrence, Local | N/A | 2017-06-19 |
| Completed | Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer Neutropenia | Phase 3 | 2017-05-15 |
| Completed | Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection Hepatocellular Carcinoma, Malignant Neoplasm | Phase 2 | 2017-01-09 |
| Unknown | Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain Pain, Physicians, Oxycodone | Phase 1 / Phase 2 | 2017-01-01 |
| Unknown | Apatinib for Advanced Non-squamous Head and Neck Cancer Head and Neck Neoplasms | Phase 2 | 2016-12-01 |
| Recruiting | MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esoph Esophagus Cancer, Esophagogastric Junction Cancer | N/A | 2016-10-01 |
| Unknown | The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer Head and Neck Neoplasms | Phase 2 | 2016-10-01 |
| Unknown | A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Neoplasms, Malignant Neoplasm of Supraglottis Primary, Neck Dislocation | N/A | 2016-10-01 |
| Unknown | Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer Lung Neoplasm | N/A | 2016-07-01 |
| Unknown | IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer Pancreatic Cancer | N/A | 2016-02-01 |
| Unknown | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-typ Lung Adenocarcinoma | Phase 1 | 2016-02-01 |
| Completed | HA-WBRT-SIB for Brain Metastasis of Lung Cancer Lung Neoplasm, Brain Metastases, Simultaneous Integrated Boost | Phase 2 | 2016-01-01 |
| Unknown | Safety and Feasibility of Laparoscopic Intracorporeal Anastomosis for Colorectal Surgery- A Multiple Center Re Colorectal Cancer | — | 2016-01-01 |
| Unknown | IORT Versus CCRT for Pancreatic Cancer Pancreatic Cancer Stage IV | N/A | 2015-12-01 |
| Unknown | Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoi Colorectal Cancer | Phase 3 | 2015-11-01 |
| Completed | Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer Bladder Cancer | N/A | 2015-09-01 |
| Unknown | Translational Research on Locally Advanced Pancreatic Adenocarcinoma Pancreatic Cancer | N/A | 2015-07-01 |
| Unknown | Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer Lung Neoplasms | N/A | 2015-05-01 |
| Completed | Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer Locally Advanced Rectal Cancer, Distant Metastasis | — | 2015-01-01 |
| Recruiting | Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Dat Lung Cancer | — | 2013-01-01 |
| Completed | Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Sur Breast Cancer | Phase 3 | 2010-06-01 |
| Unknown | Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2009-05-01 |
| Completed | A Multicenter Study on the Safety and Functionality Evaluation of Anastomotic Redo Surgery Colorectal Cancer | — | 2006-05-01 |
| Completed | The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor R Colo-rectal Cancer, Anastomosis, Leaking | — | 2006-03-01 |
| Recruiting | Neoadjuvant Treatment Modalities in Esophageal Cancer Esophageal Cancer, Chemotherapy Effect, Chemoradiation | Phase 3 | 2002-01-01 |
| Recruiting | Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation | Phase 3 | 2002-01-01 |